FDA NDC Directory · JSON-LD · Markdown

Deferasirox

NDC 69097-560 · HUMAN PRESCRIPTION DRUG · GRANULE

Labeler / ManufacturerCipla USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA215026
Dosage form / routeGRANULE · ORAL
Active ingredientsDEFERASIROX (180 mg/1)
Marketing started20220223
Package count1

External sources

Source: openFDA. Public-domain (CC0).